Clinical Study
Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray
Table 11
Comparison of the current study 1 with other azelastine studies.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Physicians assessment; 2patients’ assessment; 3one spray of 0.1% azelastine nasal spray per nostril twice daily for 14 days; 4two sprays of 0.1% or 0.15% azelastine nasal spray per nostril twice daily for 14 days; 5two sprays of 0.15% azelastine nasal spray per nostril once daily for 14 days; 6two sprays of 0.15% azelastine nasal spray per nostril once daily for 2 weeks; 7azelastine 1.12 mg/day and levocabastine 0.4 mg/day nasal spray administered twice daily for 4 weeks, TNSS: sneezing, nasal itching, and rhinorrhoea; 8one spray of 0.1% azelastine nasal spray per nostril twice daily for 14 days. n.d.: not determined. |